CooperVision, a division of CooperCompanies (NASDAQ: COO), opened The Vision Centre, a new global innovation facility in Southampton, England, and announced six planned product advancements expected to launch over the next several years.

The 9,940-square-meter, multi-story facility will house approximately 350 employees and includes advanced laboratories, pilot manufacturing capability, a clinic, customer engagement spaces, and technology-enabled environments. The company said the facility is designed to integrate research and development, clinical expertise, and commercial capabilities.

The six product advancements outlined by the company include:

• A complete family of 1-day contact lenses for myopia control
• A novel premium 1-day silicone hydrogel (SiHy) technology
• A next-generation SiHy material in a monthly contact lens
• An entry-level 1-day SiHy contact lens
• A 1-day SiHy toric multifocal contact lens
• A new toric 1-day contact lens for astigmatic patients

"The future of eye care will be shaped by collaboration, scientific advancement, and a deep understanding of the people who provide and benefit from our innovations," said Jerry Warner, President of CooperVision. "The Vision Centre provides an environment that helps our teams build on the strong collaboration that already exists across CooperVision, enabling faster learning, deeper integration, and accelerated discovery."

According to a company press release, the facility is intended to support faster product development through advanced modeling, simulation, analytics, and AI-enabled tools.